Long-term follow up of esophageal varices after balloon-occluded retrograde transvenous obliteration for gastric varices

Hepatology Research

Volumn 38, Issue 4, 2008, Pages 340-347

  Nakamura, Shinichi ^a   Torii, Nobuyuki ^a   Yatsuji, Satoru ^a   Konishi, Hiroyuki ^a   Kishino, Maiko ^a   Taniai, Makiko ^a   Tokushige, Katsutoshi ^a   Hashimoto, Etsuko ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Balloon occluded retrograde transvenous obliteration; Esophageal varices; Gastric varices; Portal hypertension

Indexed keywords

ENBUCRILATE;

AGED; ARTICLE; BALLOON OCCLUSION; BLEEDING; BLOOD VESSEL SHUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; DISEASE SEVERITY; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; HEMODYNAMICS; HUMAN; KIDNEY VEIN; MALE; OUTCOME ASSESSMENT; PATIENT CODING; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROBABILITY; SPLENIC VEIN; STOMACH VARICES; SURVIVAL RATE; SURVIVAL TIME; THROMBOSIS;

EID: 40049086378     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00282.x     Document Type: Article

References (35)

1. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: A long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16: 1343-9.
2. Kim T, Shijo H, Kokawa H et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997; 25: 307-12.
3. Lunderquist A, Vang J. Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med 1974; 291: 646-9.
4. L'Hermine C, Chasstanet P, Delemazure O, Bonniere P, Durieu J, Paris J. Percutaneous transhepatic embolization of gastroesophageal varices: result in 400 patients. AJR 1989; 152: 755-60.
5. Hassab MA. Gastro-esophageal decongestion and splenectomy in the treatment of esophageal varices in bilharzial cirrhosis: Further studies with a report on 355 operation. Surgery 1967; 61: 169-76.
6. Matsumoto A, Hamamoto N, Kayazawa M. Balloon endoscopic sclerotherapy, a novel treatment for high-risk gastric fundal varices: A pilot study. Gastroenterology 1999; 117: 515-16.
7. Shiba M, Higuchi K, Nakamura K et al. Efficacy and safety of balloon-occluded endoscopic injection sclerotherapy as a prophylactic treatment for high-risk gastric fundal varices: A prospective, randomized, comparative clinical trial. Gastrointest Endosc 2002; 56: 522-8.
8. Yoshida T, Harada T, Shigemitsu T et al. Endoscopic management of gastric varices using a detachable snare and simultaneous endoscopic sclerotherapy and O-ring ligation. J Gastroenterol Hepatol 1999; 14: 730-5.
9. Lee MS, Cho JY, Cheon YK et al. Use of detachable snares and elastic bands for endoscopic control of bleeding from large gastric varices. Gastrointest Endosc 2002; 56: 83-8.
10. Soehendra N, Grimm H, Nam VC, Berger B. N-butyl-2-cyanoacrylate: A supplement to endoscopic sclerotherapy. Endoscopy 1987; 19: 221-4.
11. Oho K, Iwao T, Toyonaga A, Tanikawa K. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: A nonrandomized study. Endoscopy 1995; 27: 349-54.
12. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33: 1060-4.
13. Olson E, Yune HY, Klatte EC. Transrenal-vein reflux ethanol sclerosis of gastrorenal varices. AJR 1984; 143: 627-8.
14. Kanagawa H, Mima H, Kouyama H et al. A successfully treated case of fundic varices by retrograde transvenous obliteration with balloon (in Japanese). Jpn J Gastroenterol 1991; 88: 1459-62.
15. Kanagawa H, Mima H, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11: 51-8.
16. Chikamori F, Shibuya S, Takase Y, Ozaki A, Fukao K. Transjugular retrograde obliteration for gastric varices. Abdom Imaging 1996; 21: 299-303.
17. Koito K, Namieno T, Nagakawa Morita K. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR 1996; 167: 1317-20.
18. Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology 1999; 211: 349-56.
19. Matsumoto A, Hamamoto N, Nomura T et al. Balloon-occluded retrograde transvenous obliteration for high-risk gastric fundal varices. Am J Gastroenterol 1999; 94: 643-9.
20. Chikamori F, Kuniyoshi N, Shibuya S et al. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery 2001; 129: 414-20.
21. Kawanaka H, Ohta M, Hashizume M et al. Portosystemic encephalopathy treated with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol 1995; 90: 508-10.
22. Akahane T, Iwasaki T, Kobayashi N et al. Changes in liver function parameter after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol 1997; 92: 1026-30.
23. Miyamoto Y, Oho K, Kumamoto M, Toyonaga A, Sata M. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J Gastroenterol Hepatol 2003; 18: 934-42.
24. The Japan Society for Portal Hypertension. The General Rules for Study of Portal Hypertension, 2nd edn. Tokyo: Kanehara Co, 2004; 37-50.
25. Matsumoto A, Kitamoto M, Imamura M et al. Three-dimensional portography using multislice helical CT is clinically useful for management of gastric fundic varices. AJR 2001; 176: 899-905.
26. Ishikawa T, Ushiki T, Mizuno K et al. CT-maximum intensity projection is a clinically useful modality for the detection of gastric varices. World J Gastroenterol 2005; 11: 7515-19.
27. Stiegmann GV, Goff JS, Sun JH, Davis D, Bozdech J. Endoscopic variceal ligation, an alternative to sclerotherapy. Gastrointest Endosc 1989; 35: 431-4.
28. Stiegmann GV, Goff JS, Michaletz-Onody PA et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992; 326: 1527-32.
29. Kitano S, Koyanagi N, Iso Y, Higashi H, Sugimachi K. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 1987; 7: 810-15.
30. Takuma Y, Nouso K, Makino Y, Saito S, Shiratori Y. Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 1245-52.
31. Ninoi T, Nakamura K, Kaminou T et al. TIPS versus transcatheter sclerotherapy for gastric varices. AJR 2004; 183: 369-76.
32. Ninoi T, Nishida N, Kaminou T et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR 2005; 184: 1340-6.
33. Kitamoto M, Imamura M, Kamada K et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR 2002; 178: 1167-74.
34. Arai H, Abe T, Shimoda R, Takagi H, Yamada T, Mori M. Emergency balloon-occluded retrograde transvenous obliteration for gastric varices. J Gastroenterol 2005; 40: 964-71.
35. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and encephalopathy. J Vasc Interv Radiol 2001; 12: 327-36.